{"id":"W3134204216","doi":"10.1016/j.thromres.2021.03.004","title":"5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC Registry","year":2021,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Pfizer Canada; Boehringer Ingelheim; Daiichi Sankyo Company; Bayer","keywords":"Rivaroxaban; Medicine; Discontinuation; Atrial fibrillation; Warfarin; Stroke (engine); Cohort; Hazard ratio; Confidence interval; Randomized controlled trial; Internal medicine; Cohort study; Clinical endpoint; Surgery","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001903163,0.0004103857,0.001223966,0.001702273,0.0002730489,0.001646191,0.000764095,0.0008777873,0.0009456145],"category_scores_gemma":[0.004568739,0.0003370566,0.001286571,0.002632614,0.0002791809,0.001372767,0.0009560151,0.0008118698,0.0003324645],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007356191,"about_ca_system_score_gemma":0.0007332363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007072068,"about_ca_topic_score_gemma":0.009772421,"domain_scores_codex":[0.997343,0.0005199941,0.0004557411,0.0007664324,0.0006036583,0.000311264],"domain_scores_gemma":[0.9961342,0.0008061221,0.001735229,0.0004884833,0.0004700898,0.0003659115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001744198,0.0001536916,0.9851077,0.0001721724,0.001821133,0.0001948624,0.00009341195,0.0007232049,0.0001277995,0.0002955392,0.003881159,0.005685025],"study_design_scores_gemma":[0.0001211949,0.0001160802,0.9970529,0.00004563721,0.0005178456,0.0001605116,0.0001029788,0.0002888641,0.00005903872,0.000106687,0.0014108,0.00001746976],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665932,0.00640872,0.0002749133,0.0004270911,0.0001004178,0.00002458428,0.02281252,0.00004326934,0.00331527],"genre_scores_gemma":[0.9675121,0.002116093,0.0002309812,0.0001848905,0.0001390045,0.00003995648,0.02917208,0.0000198053,0.0005850688],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007072068,"threshold_uncertainty_score":0.01406181,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.281032344180189,"score_gpt":0.4503697496969611,"score_spread":0.1693374055167722,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}